Replies to post #17079 on Hard to Treat Diseases (HTDS)

[sticker]

Could this be a really good development for HTDS?
I think getting Minimar out of the picture can only be positive.
Now with the cerebroprotien being approved for sale in India, HTDS might be poised to start bringing in some decent revenue. Imho.